High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era-Reference-Cited by-同舟云学术

High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era

Published:2020-01 Issue:1 Volume:22 Page:27-34
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Evernden Christopher,Dowhan Michelle,Dabas Rosy,Chaudhry Ahsan,Kalra Amit,Dharmani-Khan Poonam,Gregson Daniel,Johnson Andrew,Jupp Jennifer^ORCID,Jimenez-Zepeda Victor,Jamani Kareem,Duggan Peter,Tay Jason,Khan Faisal,Daly Andrew,Storek Jan

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference56 articles.

1. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis;Williams;Bone Marrow Transplant,2016

2. Preventing opportunistic infections in bone marrow transplant recipients;Dykewicz;Transpl Infect Dis.,1999

3. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study;De Castro;Bone Marrow Transplant,2005

4. Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation;Lyytikäinen;Bone Marrow Transplant,1996

5. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group;Phair;N Engl J Med.,1990

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathological assessment for opportunistic infections in the iatrogenically immunosuppressed;Diagnostic Histopathology;2024-07

2. Breakthrough Pneumocystis jirovecii Pneumonia in an Allogeneic Hematopoietic Stem Cell Transplant Recipient;Cureus;2024-06-07

3. Features and global impact of invasive fungal infections caused by Pneumocystis jirovecii: A systematic review to inform the World Health Organization fungal priority pathogens list;Medical Mycology;2024-06

4. Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients;Mycoses;2024-01

5. Late‐onset Pneumocystis jirovecii pneumonia post‐allogeneic stem cell transplantation after time‐dependent discontinuation of prophylaxis;European Journal of Haematology;2023-11-10